- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
ObsEva is a biotechnology & medical research business based in the US. ObsEva shares (OBSV) are listed on the NASDAQ and all prices are listed in US Dollars. ObsEva employs 48 staff and has a trailing 12-month revenue of around $3.7 million.
Our top picks for where to buy ObsEva stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy ObsEva stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – OBSV. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy ObsEva stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
ObsEva stock price (NASDAQ: OBSV)
Use our graph to track the performance of OBSV stocks over time.ObsEva shares at a glance
Information last updated 2024-06-30.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $0.14 |
| 200-day moving average | $0.27 |
| Wall St. target price | $12.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.74 |
Is it a good time to buy ObsEva stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ObsEva financials
| Revenue TTM | $3.7 million |
|---|---|
| Gross profit TTM | $17,000 |
| Return on assets TTM | -50.26% |
| Return on equity TTM | -373.98% |
| Profit margin | 0% |
| Book value | $-0.03 |
| Market Capitalization | $11 million |
TTM: trailing 12 months
ObsEva share dividends
We're not expecting ObsEva to pay a dividend over the next 12 months.
Have ObsEva's shares ever split?
ObsEva's shares were split on a 13:1 basis on 5 December 2016 . So if you had owned 1 share the day before before the split, the next day you'd have owned 13 shares. This wouldn't directly have changed the overall worth of your ObsEva shares – just the quantity. However, indirectly, the new 92.3% lower share price could have impacted the market appetite for ObsEva shares which in turn could have impacted ObsEva's share price.
ObsEva share price volatility
Over the last 12 months, ObsEva's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ObsEva's is 0.6745. This would suggest that ObsEva's shares are less volatile than average (for this exchange).
ObsEva overview
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland. .
Frequently asked questions
What percentage of ObsEva is owned by insiders or institutions?Currently 2.016% of ObsEva shares are held by insiders and 13.423% by institutions. How many people work for ObsEva?
Latest data suggests 48 work at ObsEva. When does the fiscal year end for ObsEva?
ObsEva's fiscal year ends in December. Where is ObsEva based?
ObsEva's address is: Chemin des Aulx, 12, Geneva, Switzerland, 1228 What is ObsEva's ISIN number?
ObsEva's international securities identification number is: CH0346177709 What is ObsEva's CUSIP number?
ObsEva's Committee on Uniform Securities Identification Procedures number is: H5861P103
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question